---
source_image: "court-document+letter+legal-filing+affidavit__EFTA02444174_20260210_p001_i001.png"
source_pdf: "EFTA02444174.pdf"
method: pdf_text
words: 503
confidence: 1.00
extracted: 2026-02-13T16:18:43.115804
---

VERSION N2 -.5/3/09 REVISIONS 
SUBSCRIPTION NUMBER: 
NAME OF INVESTOR: 
CONFIDENTIAL INVESTOR OUESTIONNAIRE 
LASI1RSCULPT, 
30 East 7e Street, 61h Floor 
New York, New York 10021 
Attn: Steven A. Victor, M.D. 
Chairman and Chief Executive Officer 
Gentlemen: 
The information contained in this Confidential Investor Questionnaire (the "Questionnaire") is 
being furnished to you to enable you to determine whether offers and sales by LaserSculpt, Inc. 
(the "Company"), a Delaware corporation, of certain Units comprised of (a) debentures (such 
debentures, the "Debentures") that are convertible into shares of the Company's common stock, par 
value $0.0001 per share, (such shares, the "Conversion Shares") and (b) warrants to purchase 
shares of the Company's common stock, par value 50.0001 per share, (such shares, the "Warrant 
Shares" and such warrants, the "Warrants") may be made to the undersigned pursuant to (i) 
Regulation D of the Securities Act of 1933, as amended (the "Act"), (ii) any other exemption 
from the registration provisions of the Act and (iii) exemptions from applicable registration 
provisions of state securities laws, since none of the Units, Debentures or Warrants (nor any of 
the Conversion Shares or the Warrant Shares will be registered under the Act or such laws). (The 
Debentures and Warrants comprising the Units are hereinafter sometimes referred to collectively 
as the "Constituent Securities" and the shares of the Company's common stock, par value $0.0001 
per share, (whether Conversion Shares or Warrant Shares) issuable upon the conversion of the 
Debentures and/or the exercise of the Warrants are hereinafter sometimes referred to collectively 
as the "Underlying Shares.") 
The undersigned understands that the Company will rely upon the information contained 
herein for purposes of such determination. In addition, this information will be used by the 
Company in determining whether to accept the undersigned* s subscription for any of the Units 
(and Constituent Securities comprising the Units) and to permit conversion by the undersigned of 
any Debentures held by the undersigned into any Conversion Shares or the exercise of any 
Warrants held by the undersigned for any Warrant Shares. 
The undersigned represents to you that (i) the information contained herein is complete 
and accurate and may be relied upon by you and your counsel and (ii) the undersigned will notify 
you immediately of any material change in any of such information occurring prior to (a) the 
closing of the purchase of any Units or Constituent Securities by the undersigned or (b) the 
exercise by the undersigned of (I) any right to convert any of the Debentures into Conversion 
Shares or (II) any right to acquire any Warrant Shares upon the exercise of any Warrants. 
The undersigned further represents to you that: (a) the undersigned understands that none 
of the Units, the Constituent Securities and the Underlying Shares have been registered under the 
Act or applicable state securities laws and that the Units, the Constituent Securities and the 
Underlying Shares will be offered in reliance upon the exemptions from the registration 
requirements of the Act and such state securities laws; (b) any of the Units, the Constituent 
EFTA_R1_0 1520529 
EFTA02444174
